康德萊(603987.SH):增加的遠期結售匯業務累計總額不超2100萬美元
格隆匯 10 月 9日丨康德萊(603987.SH)公佈,公司於2020年10月9日召開了公司第四屆董事會第九次會議,審議通過了《關於增加公司子公司2021年度遠期結售匯額度的議案》,本項業務不構成關聯交易,該議案無需提交公司股東大會審議。
為規避匯率波動影響、鎖定結匯成本和出口產品利潤,康德萊醫械及廣東醫械集團擬開展的遠期結售匯業務期間自本次董事會審議通過之日至2021年12月31日。在此期間,增加的遠期結售匯業務累計總額不超過2100萬美元(在此額度內,資金可循環滾動使用)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.